Analysis of the effective components and mechanism of Yufang Fangji II for prevention of COVID-19 based on UHPLC-Q-TOF/MS and network pharmacology
10.12092/j.issn.1009-2501.2021.10.005
- Author:
Guangyang JIAO
1
;
Doudou HUANG
1
;
Yong CHEN
1
;
Deduo XU
1
;
Wansheng CHEN
1
;
Feng ZHANG
1
;
Tianyi YU
2
;
Bolong WANG
2
;
Shi QIU
3
;
Wansheng CHEN
3
Author Information
1. Department of Medicinal Materials, Shanghai Changzheng Hospital
2. School of Chemistry and Bioengineering, Yichun University
3. Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Blood components;
Chemical composition;
COVID-19;
Molecular docking;
Network pharmacology;
UHPLC-Q-TOF/MS
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2021;26(10):1127-1145
- CountryChina
- Language:Chinese
-
Abstract:
AIM: The main chemical components of Yufang Fangji II (Hubei Fang) of COVID-19 were studied systematically and combined with network pharmacology to provide a reference for the study of its effective substances. METHODS: Ultra high-performance liquid chromatography quadrupole time of flight mass spectrometry (UHPLC-Q-TOF/MS) was applied to identify the absorbed components of the prescription in rat plasma. TCMSP database and Swiss Target Prediction data platform were used to predict the target of the identified blood components, and network visualization software Cytoscape 3.7.2 was used draw the association network diagram, and GO enrichment analysis and KEGG pathway enrichment analysis were conducted for the key targets. With the help of CB-Dock online molecular docking platform, the molecular docking of key targets and blood entering compounds was carried out, and the docking combination with good affinity value was displayed by ligplot software to verify the preventive effect of Yufang Fangji II on COVID-19. RESULTS: A total of 52 chemical components identified in the prescription, in which 13 components were absorbed in the rat plasma as the prototype, and they were from Astragalus membranaceus, Atractylodes macrocephala, Saposhnikoviae Radix, Lonicerae Japonicae Flos, and Citri Reticulatae Pericarpium, respectively. These compounds were recognized to act on 17 core targets, including mapk3, TNF and other targets related to inflammation, MPO and other targets related to oxidative stress, VEGFR, KDR and other targets related to vascular endothelium. The results of molecular docking showed that the absorbed components had good binding activity with the key targets. CONCLUSION: Compounds in Yufang Fangji II are involved in regulating inflammation, oxidative stress, vascular and cellular physiological activities, which have preventive effects on COVID-19 through regulating IL-17, PI3K Akt, MAPK and other pathways.
